Healthcare Giants or Medical Innovators? XLV and PINK Are Built for Different Investors.

Sara Appino, The Motley Fool

Fri, June 5, 2026 astatine 11:25 AM CDT 4 min read

The State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) provides low-cost, passive vulnerability to established healthcare giants, portion the Simplify Health Care ETF (NYSEMKT:PINK) offers an progressive strategy targeting aesculapian breakthroughs.

Investors evaluating the healthcare assemblage could take betwixt the stableness of established aesculapian giants and the high-growth imaginable of cutting-edge innovation. While some funds run wrong the aesculapian sector, they disagree importantly successful their concern philosophies. The State Street money tracks a well-known index, whereas the Simplify money employs progressive absorption led by Michael Taylor, who utilizes implicit 20 years of acquisition to navigate the complexities of the biotech and medtech industries.

Snapshot (cost & size)

Beta measures terms volatility comparative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr instrumentality represents full instrumentality implicit the trailing 12 months. Dividend output is the trailing-12-month organisation yield.

The State Street money is much affordable than the Simplify fund, carrying an disbursal ratio of conscionable 0.08% compared to 0.51%. Income seekers whitethorn besides find the State Street money much attractive, arsenic its 1.70% trailing-12-month dividend output sits 1.04 percent points higher than the Simplify money yield.

Performance & hazard examination

What's wrong

The State Street Health Care Select Sector SPDR ETF provides vulnerability to 60 holdings wrong the S&P 500 healthcare sector, spanning pharmaceuticals, wellness attraction equipment, and biotechnology. Its portfolio is weighted toward established mega-caps, with apical holdings including Eli Lilly (NYSE:LLY) astatine 15.97%, Johnson & Johnson (NYSE:JNJ) astatine 10.17%, and AbbVie (NYSE:ABBV) astatine 7.21%. This money launched successful 1998 and has a trailing-12-month dividend of $2.51 per share. It tracks a passive scale and presently reports nary unsocial concern quirks.

The Simplify Health Care ETF is an actively managed money with 58 positions that launched successful 2021. It targets high-growth innovative firms similar PureCycle Technologies (NASDAQ:PCT) astatine 10.88%, United Therapeutics (NASDAQ:UTHR) astatine 7.26%, and Novo Nordisk (NYSE:NVO) astatine 6.42%. Its portfolio tilt includes 93% healthcare and 7% industrials, and it has a trailing-12-month dividend of $0.25 per share. The money utilizes a currency hedge and is the archetypal 100% pro bono ETF, donating its nett profits to the Susan G. Komen foundation.